Loading...

CAMP CAMP4 THERAPEUTICS CORP US FDA Inspections 8-K Filing

CMP4

CMP

CAMP4 THERAPEUTICS CORP

(CAMP)

2025 8-K

New Data Release

Financial Results

Director Appointment

Financial Results Update

Corporate Update

Lease Agreement Update

Stock Offering Update

Collaboration Agreement

Financial Results Announced

Toxicology Studies Initiated

Securities Agreement

Financial Results Announcement

Product Expansion

Financial Statements

Financial Results

Board Appointments

Corporate Presentation

Financial Results

External Links:

On October 1, 2025, Camp4 Therapeutics Corp announced the initiation of GLP Toxicology Studies for CMP-SYNGAP-01, an important step in their research and development process.

AI Assistant

CAMP4 THERAPEUTICS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.